ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases

NCT07187713 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertensive Nephropathy
Auto Immune Disorders
Chronic Kidney Disease
Chronc Kidney Disease Stage 5
Chronic Kidney Disease (Stage 3-4)
Chronic Kidney Disease (Stages 4 and 5)
Microalbuminuria
Diabetic Nephropathies

Interventions

DRUG: ACE Reno

Sponsor

Ace Cells Lab Limited